Challenges in molecular diagnosis of X-linked Intellectual disability
Authors:
- 11 February 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in British Medical Bulletin
- Vol. 133 (1) , 36-48
Abstract
Background: Intellectual disability (ID) affects 1–3% of the Western population and is heterogeneous in origin. Mutations in X-linked genes represent 5–10% of ID in males. Fragile X syndrome, due to the silencing of the FMR1 gene, is the most common form of ID, with a prevalence of around 1:5000 males. Females are usually non- or mildly affected carriers, and in a few rare cases, the only gender affected. Array comparative genome hybridization (aCGH) and next-generation sequencing (NGS) have dramatically changed the nature of human genome analysis leading to the identification of new X-linked intellectual disability syndromes and disease-causing genes. Sources of data: Original papers, reviews, guidelines and experiences of the diagnostic laboratories. Areas of agreement: Family history and clinical examination still are essential to choose the appropriate diagnostic tests, including, a disease-specific genetic test, aCGH or FMR1 molecular analysis. If negative, NGS approaches like well-defined gene panels, whole exome, or even whole genome sequencing, are increasingly being used, improving diagnostics and leading to the identification of novel disease mechanisms. Areas of controversy: The main challenge in the era of NGS is filtering and interpretation of the data generated by the analysis of a single individual. In X-linked cases, assessing pathogenicity is particularly challenging, even more when the variant is found to be inherited from a healthy carrier mother or when a heterozygous X-linked mutation is found in an impaired female. Growing points: At present, variant interpretation remains a challenging task, especially in X-linked disorders. We review the main difficulties and propose a comprehensive overview that might aid in variant interpretation. Establishing a genetic diagnosis facilitates counseling and allows better delineation of clinical phenotypes. Areas timely for developing research: To improve variant interpretation, there is need to refine in silico predictions with specific criteria for each gene, and to develop cost-effective functional tools, which can be easily transferred to diagnostics.Keywords
This publication has 44 references indexed in Scilit:
- Fragile X and X-Linked Intellectual Disability: Four Decades of DiscoveryThe American Journal of Human Genetics, 2012
- A Simple, High-Throughput Assay for Fragile X Expanded Alleles Using Triple Repeat Primed PCR and Capillary ElectrophoresisThe Journal of Molecular Diagnostics, 2010
- X‐linked intellectual disability: Unique vulnerability of the male genomeDevelopmental Disabilities Research Reviews, 2009
- Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental RetardationThe American Journal of Human Genetics, 2008
- Restoring reproductive confidence in families with X‐linked mental retardation by finding the causal mutationClinical Genetics, 2007
- MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous motherBrain and Development, 2007
- X-inactivation and human disease: X-linked dominant male-lethal disordersCurrent Opinion in Genetics & Development, 2006
- X‐linked mental retardation: further lumping, splitting and emerging phenotypesClinical Genetics, 2005
- X-inactivation profile reveals extensive variability in X-linked gene expression in femalesNature, 2005
- X-linked mental retardationNature Reviews Genetics, 2005